Is this 8.2%-yielding income share a bargain or a value trap?

This UK income share sells for pennies and has a yield of over 8%. Our writer sees merit in the business model — but what about the balance sheet?

| More on:

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

One income share I have been eyeing for a while as a possible addition to my portfolio has fallen 15% so far this year. That, combined with a dividend increase, means the FTSE 250 share now yields 8.2%.

Could now be the time to swoop while the share continues to trade at current levels (45% cheaper than it was five years ago)? Or might the falling share price and high yield be warning signals of a classic value trap?

Attractive but complicated business sector

The share in question is Assura (LSE: AGR). Although the property company is far from a household name, its buildings are used at least occasionally by a sizeable part of the population. It specialises in healthcare properties, such as GP practice buildings and ambulance depots.

I think this is potentially an attractive business area, but not necessarily a straightforward one.

On the plus side, demand for healthcare services is resilient and I reckon if anything it will only grow over time. Those services require buildings in many cases. A GP surgery is exactly the sort of tenant I would be happy to have if I was a commercial landlord. In many cases it will stay in situ for decades. Any tenant can fall behind on rent, but this seems less likely with a GP surgery than a fashionable new retailer that is growing quickly, for example.

But I also see some challenges here. Putting up buildings with a specific purpose in mind can mean they are more costly to convert for other uses if that happens at some point in future. Plus, healthcare is and is likely to remain a politically contentious topic. Making big profits from it could be a double-edged sword when it comes to corporate reputation and also the potential for future rent increases.

Debt-heavy Assura has its work cut out

Still, with net rental income of £143m last year, Assura has proven it can operate a sizeable property portfolio focused on the healthcare sector and collect sizeable rents.

But doing that has involved borrowing a lot of money. Assura ended last year with £1.2bn in net debt. That is not far short of its current market capitalisation of £1.3bn.

Here, the investment case moves more closely to that of any property company, in my view.

To expand, Assura has borrowed. Servicing that debt is burdensome. Given the poor track record of the income share when it comes to price, growing the dividend each year likely helps to sustain some investor enthusiasm.

But dividends just add to the company’s need for cash. Indeed, last year, Assura spent £86m paying dividends. That represented a sizeable chunk of the £102m it generated in net cash inflow from operating activities. With £98m of net cash outflow from investing activities, the company saw more cash go out the door last year than come in.

Funding its balance sheet and the dividend (with or without growing it) will remain a challenge, in my view. Given the balance of risks and rewards, for now I will not be adding the income share to my portfolio.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

C Ruane has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Buying 12,487 shares of this high-yield FTSE dividend stock gives me a £100 monthly income

Harvey Jones is wondering how much more he would need to invest in this 6% yielding FTSE 100 dividend stock…

Read more »

Elevated view over city of London skyline
Investing Articles

With a P/E of 7.5 and a 6.8% yield, are HSBC shares a steal?

After rising 89% since September 2021, HSBC shares are currently just off a six-year high. But do they still offer…

Read more »

Buffett at the BRK AGM
Investing For Beginners

2 ways I’m imitating Warren Buffett when preparing for a stock market crash

Jon Smith considers some quotes from Warren Buffett when dealing with volatile markets and explains how he's putting them into…

Read more »

Investing Articles

This UK share yields almost 9% — and keeps raising its dividend!

Christopher Ruane highlights some of the strengths and weaknesses he sees in the investment case for a blue-chip UK share…

Read more »

Investing Articles

As Q3 results give the Standard Chartered share price a boost, should I buy?

The Standard Chartered share price has had a terrific 12 months, and it's passed under my radar. It might be…

Read more »

Happy woman with excess weight smiling and dancing alone in sports clothes
Investing Articles

Next has done it again and the share price looks set to continue its climb

I'd forget ASOS and boohoo. Next has been quietly succeeding and the share price has been rising as its growth…

Read more »

Investing Articles

Should I buy GSK shares at £14 after the Q3 trading update?

This writer thinks GSK shares appear very cheap after the Q3 results, making him wonder if now's the time for…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

AMD stock slides as Q3 results miss analyst expectations. Should I sell?

A highly-anticipated Q3 earnings call has left shareholders disappointed as AMD stock dipped in after-hours trading. Our writer considers his…

Read more »